Tag: preclinical
-

Covid-19 Antibody Therapy Prepares for Trial
A biotechnology company producing synthetic antibodies in cattle, without human blood, to treat Covid-19 infections is advancing the therapy toward a clinical trial.
-

Anti-Viral Drug Treats Some Severe Covid-19 Cases
A report of early use of the anti-viral therapy remdesivir shows most patients with severe cases of Covid-19 infections responded to the drug.
-

Five Covid-19 Vaccines in Clinical Trials
A review of vaccines for preventing Covid-19 infections shows five of those projects are in early-stage clinical trials, with 18 more in preclinical stage.
-

Covid-19 Vaccine in Development, Trial Planned
A biotechnology company specializing in infectious diseases is developing a vaccine to protect against Covid-19 infections, with a clinical trial to start next month.
-

Trial to Test Electronic-Aided Covid-19 Vaccine
A company developing cancer immunotherapies is adapting its electronic-assisted process to create a vaccine protecting against Covid-19 infections.
-

Sanofi, Biotech Partner on RNA Covid-19 Vaccine
Drug maker Sanofi and biotechnology company Translate Bio are creating a new vaccine to protect against the virus causing Covid-19 infections
-

Engineered Blood Cells Created for Cancer Therapies
An academic lab and spin-off company are developing engineered white blood cells with added cancer-killing proteins to attack solid tumor cancers.
-

Engineered Probiotic Maker Gains $2.3M Seed Funding
A developer of genetically-modified bacteria designed to work in the gut is raising $2.3 million more in seed funds to expand its product line.
-

Business-Foundation Alliance Funds Covid-19 Treatments
Two foundations and a credit card company are providing seed money for development and manufacture of treatments for the novel coronavirus or Covid-19 pandemic.
-

Venom-Aided Immunotherapy Designed for Brain Tumors
Cancer researchers developed engineered immune-system cells, helped by peptides from scorpion venom, that in lab mice bind more reliably to brain tumor cells.